| NCT ID | NCT06666608 |
| Status | Recruiting |
| Phase | — |
| Sponsor | The Methodist Hospital Research Institute |
| Condition | Spondylolysis |
| Study Type | INTERVENTIONAL |
| Enrollment | 48 participants |
| Start Date | 2025-12-03 |
| Primary Completion | 2027-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 48 participants in total. It began in 2025-12-03 with a primary completion date of 2027-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This prospective study aims to investigate the effectiveness of bone stimulator therapy as adjunct treatment of spondylolysis in athletic populations. By evaluating its impact on pain reduction, functional improvement, osseous bony union and return-to-sport time, the investigators seek to provide valuable insights into the role of bone stimulation therapy as a potential treatment modality for this challenging condition.
Eligibility Criteria
Inclusion Criteria: * Patients between the ages of 16 to 40 years of age diagnosed with symptomatic spondylolysis by one of the investigators * Patients who plan to attend prescribed physical therapy * Patients who participate in a regular sport whether that be professional, collegiate or recreational Exclusion Criteria: * Any condition which in the investigator's opinion, would interfere with the subject's ability to comply with study instructions * Patients with contraindications to bone stimulator therapy * Patients with pacemaker and implantable cardioverter defibrillator * Patients with previous spine surgery * Patients with metabolic bone conditions * Patients who use nicotine products * Vulnerable populations * Non-English speaking services
Contact & Investigator
Mark Prasarn, MD
PRINCIPAL INVESTIGATOR
The Methodist Hospital Research Institute
Frequently Asked Questions
Who can join the NCT06666608 clinical trial?
This trial is open to participants of all sexes, aged 16 Years or older, up to 40 Years, studying Spondylolysis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06666608 currently recruiting?
Yes, NCT06666608 is actively recruiting participants. Contact the research team at hmgoble@houstonmethodist.org for enrollment information.
Where is the NCT06666608 trial being conducted?
This trial is being conducted at Houston, United States.
Who is sponsoring the NCT06666608 clinical trial?
NCT06666608 is sponsored by The Methodist Hospital Research Institute. The principal investigator is Mark Prasarn, MD at The Methodist Hospital Research Institute. The trial plans to enroll 48 participants.